tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

News

All

Editors' Picks

Stocks

Indices

Market Movers

Commodities

Cryptocurrencies

Forex

Presentations

Earnings

Transcripts

Technical Analysis

Economic Indicator

Other

KULR Q2 2026 Earnings Call: Revenue Falls to $2.1M as Battery Focus Tightens

KULR’s Q2 2026 earnings call covered $2.1 million revenue, a gross loss, Bitcoin divestment, debt repayment and expectations for a second-half battery ramp.
iconKULR Technology Group Inc
TradingKey
Fri, Aug 14

Kornit Digital (KRNT) Q2 2026 Earnings Call: ARR Growth and Higher Full-Year Outlook

Kornit Digital’s Q2 2026 earnings call covered 11.2% revenue growth, 79% ARR growth, positive adjusted EBITDA and stronger second-half guidance.
iconKornit Digital Ltd
TradingKey
Fri, Aug 14

Knightscope (KSCP) Q2 2026 Earnings Call: Revenue Hits Record $9M

Knightscope’s Q2 2026 earnings call covered record $9 million revenue, a positive gross margin, higher R&D spending and planned Q4 K7 deployments.
iconKnightscope Inc
TradingKey
Fri, Aug 14

Karyopharm (KPTI) Q2 2026 Earnings Call: Selinexor sNDA and Liquidity Focus

Karyopharm’s Q2 2026 earnings call covered $33.4 million in revenue, an August selinexor sNDA target, reaffirmed guidance and near-term liquidity risk.
iconKaryopharm Therapeutics Inc
TradingKey
Fri, Aug 14

KinderCare (KLC) Q2 2026 Earnings Call: Guidance Updated as Center Closures Expand

KinderCare (KLC) Q2 2026 revenue was $698 million as enrollment pressure weighed on EBITDA. Management updated guidance and detailed center closures.
iconKindercare Learning Companies Inc
TradingKey
Fri, Aug 14

Kamada (KMDA) Q2 2026 Earnings Call: Record Revenue, Guidance Reaffirmed

Kamada Q2 2026 earnings call: revenue rose 23% to a record $54.9 million, EBITDA margin held at 26%, and 2026 guidance was reaffirmed.
iconKamada Ltd
TradingKey
Fri, Aug 14

Intellicheck (IDN) Q2 2026 Earnings Call: Major Customer Review Shapes Outlook

Intellicheck Q2 2026 revenue reached $5.9 million with $1.1 million adjusted EBITDA, while a major customer review led to cautious full-year guidance.
iconIntellicheck Inc
TradingKey
Fri, Aug 14

Jumia (JMIA) Q2 2026 Earnings Call: Loss Narrows, GMV Guidance Revised

Jumia Q2 2026 earnings call: GMV rose 23%, adjusted EBITDA loss narrowed 36%, guidance was revised, and a $50 million capital raise was announced.
iconJumia Technologies AG
TradingKey
Fri, Aug 14

Nauticus Robotics (KITT) Q2 2026 Earnings Call: Defense and ToolKITT Take Focus

Nauticus Robotics Q2 2026 revenue rose sequentially to $0.9 million, while its net loss widened to $11.1 million as defense and ToolKITT gained focus.
iconNauticus Robotics Inc
TradingKey
Fri, Aug 14

Ituran (ITRN) Q2 2026 Earnings Call: Record Revenue and 25% Subscription Growth

Ituran's Q2 2026 earnings call covered record $104.8 million revenue, 25% subscription growth, 41,000 net additions and OEM and big data expansion.
iconIturan Location and Control Ltd
TradingKey
Fri, Aug 14

Innovative Aerosystems (ISSC) Fiscal Q3 2026 Earnings Call: Margin Expansion and Q4 Guidance

Innovative Aerosystems fiscal Q3 2026 revenue rose 11% to $26.7 million, gross margin reached 51.7%, and Q4 revenue guidance was set at $28-$30 million.
iconInnovative Solutions and Support Inc
TradingKey
Fri, Aug 14

MiNK Therapeutics (INKT) Q2 2026 Earnings Call: agenT-797 ARDS Trial Advances

MiNK Therapeutics Q2 2026 earnings call: net loss narrowed to $3.1 million, cash ended at $8.8 million, and agenT-797 Phase 2 ARDS data are due in early 2027.
iconMink Therapeutics Inc
TradingKey
Fri, Aug 14

Ideal Power (IPWR) Q2 2026 Earnings Call: Sales Funnel Tops $400 Million

Ideal Power’s Q2 2026 earnings call covered a $400 million-plus sales funnel, $41.3 million in cash and new B-TRAN data center milestones.
iconIdeal Power Inc
TradingKey
Fri, Aug 14

Intellinetics (INLX) Q2 2026 Earnings Call: SaaS Growth and Wider Net Loss

Intellinetics Q2 2026 revenue fell 1.6% to $3.9 million, while SaaS revenue grew 4.2%. Management maintained double-digit fiscal 2026 SaaS growth guidance.
iconIntellinetics Inc
TradingKey
Fri, Aug 14

SeaStar Medical (ICU) Q2 2026 Earnings Call: Revenue Up 82%, AKI Trial Advances

SeaStar Medical’s Q2 2026 earnings call covered 82% revenue growth, QUELIMMUNE adoption at 20 hospitals and 223 patients enrolled in its adult AKI trial.
iconSeaStar Medical Holding Corp
TradingKey
Fri, Aug 14

Hyperion DeFi (HYPD) Q2 2026 Earnings Call: Adjusted Gross Profit Rises 20%

Hyperion DeFi Q2 2026 adjusted gross profit rose 20% to $1.2 million as costs declined. HYPD reaffirmed $5 million-$7 million full-year guidance.
iconHyperion Defi Ord Shs
TradingKey
Fri, Aug 14

IceCure Medical (ICCM) Q2 2026 Earnings Call: H1 Revenue Rises 45%

IceCure Medical’s Q2 2026 earnings call covered 45% H1 revenue growth to $1.8 million, a 30% gross margin and upcoming CHoICE enrollment.
iconIcecure Medical Ltd
TradingKey
Fri, Aug 14

Humacyte (HUMA) Q2 2026 Earnings Call: Dialysis sBLA Targeted for November

Humacyte’s Q2 2026 earnings call covered $0.4 million in sales, positive V012 dialysis data and a November target for its ATEV sBLA filing.
iconHumacyte Inc
TradingKey
Fri, Aug 14

HeartFlow (HTFL) Q2 2026 Earnings Call: Revenue Up 48%, Guidance Raised

HeartFlow (HTFL) Q2 2026 earnings call: revenue rose 48% to $64.1 million as management raised 2026 revenue guidance to $246 million-$250 million.
iconHeartflow Inc
TradingKey
Fri, Aug 14

Heritage Global (HGBL) Q2 2026 Earnings Call: $21.7M Wind-Down Charge

Heritage Global’s Q2 2026 earnings call covered a $21.7M HGC wind-down charge, $12.3M revenue, a $15.9M net loss and the Boston Note acquisition.
iconHeritage Global Inc
TradingKey
Fri, Aug 14
Featured Tools
marketing_marketsTitleMarketscalendar_economicCalendarEconomic Calendarsearch.intelligent.strategySmartPicksarticle_asider_weekly_reportWeekly Report
Popular Instruments
link
Name
Price
Chg%
US30
US30
US30
--
--
NAS100
NAS100
NAS100
--
--
SPX500
SPX500
US500
--
--
Top News
link
Meta Q3 Net Profit Surges 264% YoY, Raises Full-Year Capex Slightly; Shares Briefly Rise Over 4% After Hours
Tesla Q3 Operating Profit Plunges 56% YoY, Dragged Down by Higher Operating Expenses Including R&D
Meta Q3 2026 Earnings: Legal Charge Halves Operating Margin Despite 26% Revenue Growth
US Stocks Close: Nasdaq Gains Over 1%, Philadelphia Semiconductor Index Rises Nearly 2%; Tech Stocks Strengthen, SpaceX Gains Nearly 8% Post-Earnings
Meta Q3 Earnings Preview: Muse Commercialization Faces Test, Wall Street High Target Price Hits $1,000
Market Movers
link
Silver/AUD (XAGAUD) Is down 2.12% on Oct 22: What Is Driving the Move?
53 minutes ago
XAGAUD
--
Micro Silver (XAGUSD-M) Moved Sharply on Oct 22: Inventories, the Dollar, or Geopolitics?
an hour ago
XAGUSD-M
--
Silver (XAGUSD) Drops on Oct 22: What Lie behind the Move?
an hour ago
XAGUSD
--
Palladium (XPDUSD) Is down 2.53% on Oct 22: Is the Market Repricing It?
2 hours ago
XPDUSD
--
Bitcoin (BTCUSD) Volatility Intensified on Oct 22: What You Should Know
2 hours ago
BTCUSD
--
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy